Skip to search formSkip to main contentSkip to account menu

8-bromo-7-methoxychrysin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
We have previously reported that 8-bromo-7-methoxychrysin (BrMC), a novel synthetic derivative of chrysin, was demonstrated anti… 
2019
2019
BackgroundOur previous works have demonstrated that 8-bromo-7-methoxychrysin suppressed stemness of human hepatocellular… 
2017
2017
BACKGROUND Hepatocellular carcinoma (HCC) is related to chronic liver inflammation. M2 polarization of tumor-associated… 
2017
2017
Signal transducer and activator of transcription 3 (STAT3) is a member of the family of latent cytoplasmic transcriptional… 
2016
2016
Hepatic stellate cells (HSCs) that are activated by human hepatocellular carcinoma (HCC) cells secrete a variety of cytokines… 
2016
2016
Sorafenib, a multi-kinase inhibitor, has shown its promising antitumor effect in a series of clinical trials, and has been… 
2015
2015
8-bromo-7-methoxychrysin (BrMC), a novel chrysin analog, was reported to have anti-cancer activities. The aim of the present… 
2013
2013
AIM To evaluate whether 8-bromo-7-methoxychrysin (BrMC), a synthetic analogue of chrysin, inhibits the properties of cancer stem… 
2013
2013
Emerging evidence has suggested that cancer stem cells with expression of surface biomarkers including CD133 and CD44 have more… 
Highly Cited
2010
Highly Cited
2010
AIM To investigate whether the apoptotic activities of 8-bromo-7-methoxychrysin (BrMC) involve reactive oxygen species (ROS…